E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/18/2015 in the Prospect News Bank Loan Daily and Prospect News High Yield Daily.

Syndication underway for Rite Aid’s $1.8 billion bridge loan, to be taken out with bonds via Citi

By Paul A. Harris

Portland, Ore., Feb. 18 – A syndication effort is underway for Rite Aid Corp.’s $1.8 billion senior unsecured bridge loan, according to a high-yield portfolio manager.

The bridge is expected to be taken out with junk bonds in a deal to be led by Citigroup, sources say.

The loan backing the $1.8 billion cash portion of Rite Aid’s $2 billion acquisition of Twinsburg, Ohio-based pharmacy benefit management company Envision Pharmaceutical Services (EnvisionRx) is priced at Libor plus 600 basis points with a 1% Libor floor. It is capped at 9¼%; however, that rate would increase to 9½% after 120 days. Participants receive a 50 bps fee.

As reported, Rite Aid expects to come to the market during the March-April timeframe.

Rite Aid is a Camp Hill, Pa.-based drugstore chain.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.